Submitted by Anonymous (not verified) on 7 November 2023 - 14:50
Human medicines European public assessment report (EPAR): Zejula, niraparib, Fallopian Tube Neoplasms;Peritoneal Neoplasms;Ovarian Neoplasms, Date of authorisation: 16/11/2017, Revision: 22, Status: Authorised
Source: